+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Prostate Cancer Research Grant Competition

Cancer Research Society, Inc.

Prostate cancer is the most commonly diagnosed cancer in Canada, affecting one in seven men over their lifetime. Despite its high prevalence, significant challenges remain in the fight against this disease.

To address this critical issue, the Cancer Research Society, in partnership with PROCURE, is proud to launch a competition aimed at supporting cutting-edge translational research in prostate cancer.

Through this partnership, $2 million will be allocated to fund 4 groundbreaking research projects focused on:

Improving early detection
Developing more effective treatments

Budget Period Detail: Indicate, in Canadian dollars, the financial requirements. This grant isvlimited to a maximum of $500,000 over 3 years. Funds may not be transferred outside Canada.

AI Based Application Success Predictor

1. 🎯 Canadian-Based Researchers with Independent Labs

Eligibility: Principal Investigators must hold an academic appointment at a Canadian institution and lead their own lab capable of supporting students and postdocs
(postdocs or research scientists without faculty status are not eligible)

Projects must be led locally and contribute to Canada-focused cancer research.

2. 📚 Project Focus Falls Within CRS Priority Areas

Funded research areas include:

Fundamental/basic cancer research

Prevention science

Early translational work (biomarkers, imaging, models)

Environmental causes of cancer (e.g., viruses, pollutants, lifestyle)

Survivorship research (in CIHR partnership)

Note: Clinical trials, psychosocial studies, applied tool development, or economic analyses are ineligible

3. 🧪 Scientific Merit, Originality & Feasibility

Reviewers look for: strong novelty, sound science, clear rationale, and feasible execution within the 2-year grant window (~CAD 67,500/year)

High-quality pilot data boosts credibility—even for junior applicants aiming to build toward larger grants.

4. 🧾 Structured Peer Review and Rigor

Funding decisions are based on peer review by expert scientists and clinicians across Canada

Proposal evaluation uses predefined criteria: significance, innovation, methodology, investigator experience, environment, and impact

5. 🧭 Program-Specific Requirements & Career Stage Alignment

Operating Grants: For faculty-level researchers at all career stages, with one application per PI per cycle

Next Generation of Scientists Awards: Designed for postdocs launching independent labs

Doctoral Research Awards: Only for doctoral students in earlier stages of their PhD (12–36 months in), up to CAD 70,000 over 2 years; Canadian residency required

6. 📆 Timely Submission of Mandatory Letter of Intent (LOI)

CRS uses a two-stage process—LOI first, then invited full application.

For the 2025 Operating Grant:

Call opens Nov 14, 2024

LOI due Dec 10, 2024 (ET)

Full application if invited due Feb 11, 2025

7. 🌱 Track Record & Institutional Support

Funders value strong publication history, prior funding, and institutional support

Successful applications often come from investigators with recognized research environments and mentorship capacity

While independent early-career applicants may compete, established labs have shown consistent success.

✅ Summary Table

Success Factor	What it Means for Your Application
Canadian academic PI	Must hold faculty appointment and lead an independent lab
Fit within CRS mandates	Focus on basic/translational cancer research (not tools or behavioral studies)
Scientific rigor & novelty	Clear innovation, strong pilot data, feasible design
Peer-reviewed evaluation	Based on standard criteria across CRS committees
Career-stage alignment	Submit to category (Operating, Postdoc, Doctoral) that matches you
Timely LOI submission	Required first step—missing LOI means no invitation for full proposal
Institutional strength	Evidence of strong mentorship, infrastructure, and prior productivity

Specialties

Cancer

Eligibility Requirements

Principal investigator and co-applicants must hold a research position at a Canadian institution and be able to hold research funds at their institution. Collaborators may be affiliated with institutions outside of Canada however, cross-Canada collaborations are encouraged.

Sponsor Details

Sponsor Institute/Organizations: Cancer Research Society, Inc.

Sponsor Type: Corporate/Non-Profit

Address: 625 Av. du Président-Kennedy, Montréal, QC H3A 1K2

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity